21 participants
A Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of BRII-5395 in Combination With Sintilimab and Bevacizumab in Advanced Hepatitis B Virus Related Hepatocellular Carcinoma
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-31
- Start Date:
- 2026-08-12
- Completion:
- 2028-12-31
Conditions
- Advanced HBV-Related Hepatocellular Carcinoma
Interventions
- DRUG
No Results Yet